Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on D Alanine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104761582A details a mild route for Sofosbuvir intermediates ensuring high purity and scalable manufacturing for global supply chain reliability.
Patent CN102586384B reveals a novel deracemization method for D-amino acids using Alcaligenes faecalis, offering high optical purity and simplified downstream processing for pharmaceutical supply chains.
Patent CN105821090A details a novel NAD(H)-dependent StDapdh mutant for D-alanine synthesis, offering enhanced stability and cost-effective biocatalytic manufacturing solutions.
Patent CN101589028A details a scalable process for alpha4 integrin inhibitor intermediates with superior yields and purity for pharmaceutical manufacturing.
Patent CN1176903C reveals a novel catalytic hydrogenation route for N-[(S)-1-carboxybutyl]-S-alanine ester, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN101186944B details enzymatic hydrolysis for chiral amino acids. Offers cleaner production and scalable supply chain solutions for pharmaceutical intermediates.
Patent CN101547893B reveals a novel salt recovery method for biphenylalanine, enabling cost reduction in pharmaceutical intermediate manufacturing through direct extraction and recycling.
Patent CN116332780A reveals a high-yield synthesis for cycloserine intermediates. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN106191150A details a co-immobilized enzymatic method for D-alanine. Achieves >98% purity with continuous 55-day operation, offering significant supply chain stability and cost reduction.
Novel diazotization route avoids toxic cyanide. Scalable cosmetic intermediate manufacturing with high purity and reduced environmental impact.
Novel S173Q/Q360Y mutant enzyme boosts D-alanine yield by 20% and stability 3-fold, offering cost-effective pharma intermediate solutions.
Patent CN102234240B details a high-yield L-BMAA synthesis. Discover cost reduction in pharmaceutical intermediate manufacturing and scalable supply solutions.
Novel resolution method for levodopa intermediate ensures high purity and cost efficiency. Reliable supply chain partner for pharmaceutical manufacturing needs.
Patent CN112661671A details a cost-effective synthesis of Sacubitril intermediates using phenylhydrazine coupling, offering significant supply chain advantages.
Novel two-step Pd-catalyzed route reduces cost and improves supply chain reliability for high-purity pharmaceutical intermediates manufacturing globally with scalable efficiency.
Patent CN101696185A details a high-yield chiral synthesis route. We offer reliable supply and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN101175715B details Rh-catalyzed hydrogenation using PhanePhos for high-purity 3,3-diarylalanine intermediates, offering scalable API synthesis solutions.
Novel alcohol-ketone-water recrystallization achieves 99% purity for ketophenylalanine calcium intermediates reducing downstream refinement needs and ensuring supply chain stability effectively
Patent CN102984945B details a high-yield asymmetric hydrogenation process for Ramipril and Perindopril intermediates, offering significant cost and purity advantages for pharmaceutical supply chains.
Solve PF-07321332 synthesis challenges: 76%+ yield, 98% purity, mild conditions. Eliminate -78°C steps & column chromatography. Scale to 100MT/yr.